Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: 509 Prospective Surveillance and Treatment of De Novo Donor Specific Antibodies after Lung Transplantation Ameliorates 1-Year Risk of BOS, The Journal of Heart and Lung Transplantation, April 2012, Elsevier,
DOI: 10.1016/j.healun.2012.01.521.
You can read the full text:

Read

Contributors

The following have contributed to this page